Log In
Print
BCIQ
Print
Print this Print this
 

Cat-PAD, Cat-SPIRE, ToleroMune cat allergy therapy

Also known as: ToleroMune Cat Dander

  Manage Alerts
Collapse Summary General Information
Company Circassia Pharmaceuticals plc
DescriptionT cell vaccine using ToleroMune T cell epitope desensitization technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat cat allergy; Treat cat dander allergy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today